Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban for resolution of LAA thrombi in NVAF
NCT03840291Phase 4Completed
- Start
- May 2019
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of edoxaban in left atrial appendage thrombus. Started May 2019; status: completed.
02
Drugs
edoxaban
03
Conditions
left atrial appendage thrombus
Beyond the preview
Go deeper on NCT03840291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03840291.